Clinical Trial Update: A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating Cemsidomide in combination with dexamethasone for relapsed/refractory multiple myeloma; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Cemsidomide (Cemsidomide)
• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: C4 Therapeutics, Inc. | Conditions: Multiple Myeloma, Relapsed/Refractory Multiple Myeloma | Phase 2 | Status: RECRUITING